-
receptor as well ligand-gated ion channel for the treatment of several diseases. Such a candidate will support the preclinical drug discovery and development for early-stage therapeutic for the treatment
-
for assigned projects or product(s) across all phases of product development aimed at achieving marketing authorization and appropriate product labeling Assist in planning, authoring, reviewing and preparing
-
care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development to prepare fellows for a successful career in the pharmaceutical industry
-
at Alnylam that pairs scientific acumen with practical clinical knowledge to enable efficient and effective drug development. Clinical Scientists contribute throughout the development cycle from Phase 1 to IND
-
, and adaptable individuals seeking unique experiences and professional growth within Global Medical Affairs. Key Responsibilities: Execute scientific communication strategy for early- and late-stage
-
Development Support: Gain expertise in regulatory requirements for both early- and late-phase clinical development programs. Global Regulatory Affairs Exposure: Develop understanding across key functional areas
-
the development phase of our therapies that we can also craft our clinical trial protocols with the patient experience at the forefront. Eidos is an affiliate that operates under the BridgeBio umbrella. We
-
seeking unique experiences and professional growth within Global Medical Affairs. Key Responsibilities: Execute scientific communication strategy for early- and late-stage programs Contribute
-
marketing requirements and commitments Assist in the development of regulatory strategies for assigned projects or product(s) across all phases of product development aimed at achieving marketing
-
the development phase of our therapies that we can also craft our clinical trial protocols with the patient experience at the forefront. Eidos is an affiliate that operates under the BridgeBio umbrella. We